Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

SpinalCyte reports data from phase I/II trial of CybroCell

April 4, 2018

Phase I trial of KA-34 is currently recruiting participants

April 4, 2018

Novel secretomes disclosed by researchers from Korea

April 4, 2018

Albert Einstein College of Medicine patents MSC-derived microvesicles

April 3, 2018

First patient enrolled in phase IIb trial of AmnioFix Injectable for the treatment of OA of the knee

March 29, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

EMA committee backs approval of Sandoz's biosimilar infliximab

March 26, 2018

Argenx expands pipeline with ARGX-117 for autoimmune diseases

March 23, 2018

DiscGenics studies IDCT in patients with symptomatic lumbar intervertebral disc degeneration

March 23, 2018

GlaxoSmithKline initiates first-in-human study of GSK-3358699

March 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...